Malaria News and Research

Latest Malaria News and Research

GlobalPost examines Pres. Obama's Global Health Initiative

GlobalPost has published two articles on President Barack Obama's Global Health Initiative. "In a series of reports over the coming months from Washington and in capitals around the world, GlobalPost will examine the behind-the-scenes decisions in the Obama administration as well as what diplomats and health experts are doing now in several countries to try to bring to life this new, but what some say is a stumbling approach in global health," the publication writes.

11 May 2011

HIV drugs can be used to target malaria and other parasitic diseases

Drugs used to treat HIV may form templates for lifesaving drugs targeted at malaria and other parasitic diseases, according to a new study from Cardiff University.

10 May 2011

Uganda: First vaccination for GMZ2 malaria vaccine trial

Today, the EDCTP-funded GMZ2 consortium starts volunteer enrolment for the phase IIb clinical trial of the candidate malaria vaccine GMZ2 in Uganda. This is the third trial site to initiate volunteer recruitment for this multi-country study. Vaccination is already underway at trial sites in Gabon (November 2010) and Burkina Faso (April 2011). The Uganda site is in the peri-urban area of Iganga/Mayuge, at the Iganga Hospital. Akin to most areas in Uganda, malaria is one of the major health problems in this district. A team from Makerere University (Kampala) is conducting the trial.

9 May 2011

World's first urine-based tuberculosis diagnostics tool

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostics systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, in a new video today unveiled the world's first urine-based tuberculosis diagnostics tool.

9 May 2011

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of immune responses induced by VGX-3100, its investigational DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus.

9 May 2011

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the prestigious journal Current Opinion in Immunology has published an article in its current issue entitled, "Electroporation Delivery of DNA Vaccines: Prospects for Success."

7 May 2011

Cempra to present solithromycin Phase 1 study data at ECCMID/ICC meeting

Cempra Pharmaceuticals, a developer of differentiated antibiotics, today announced an oral presentation showing that intravenous (IV) solithromycin demonstrates excellent tolerability and a favorable pharmacokinetic profile at IV doses up to 800 mg.

7 May 2011

African Progress Panel report highlights status of African economies at World Economic Forum on Africa

Africa's economies are expanding, but the continent is still too dependent on the export of raw materials and trade between African nations needs to be increased, the African Progress Panel said in a report released Thursday at the World Economic Forum on Africa, which is taking place this week in Cape Town, the Associated Press/Washington Post reports.

7 May 2011

Opinions: U.S. support for maternal, child health; infection control at borders; the AMFm model; International Affairs budget; organizations supporting women

When Mother's Day is recognized on Sunday, "let's honor motherhood itself by giving all moms the gift they want most - the chance to deliver and raise healthy children," former Sens. Bill Frist and Jon Corzine, who serve as co-chairs of the Save the Children's Newborn and Child Survival Campaign, write in The Hill's "Congress Blog."

6 May 2011

Ben-Gurion U. researcher receives Gates Foundation grant to develop fast, low-cost malaria device

Ben-Gurion University of the Negev researcher Alberto Bilenca, Ph.D., has been awarded a prestigious grant from the Bill & Melinda Gates Foundation to develop the a fast, low-cost device to accuracy diagnose malaria without the need for blood collection in field settings.

6 May 2011

Anacor first quarter revenues increase to $2.2 million

Anacor Pharmaceuticals reviewed today its first quarter accomplishments and reported financial results for the quarter ended March 31, 2011.

5 May 2011

NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign

Tulsa Shock guard Andrea Riley and Basketball Hall of Famer Bob Lanier teamed up with NBA Cares and the Society for Adolescent Health and Medicine today to bring Vaccines for Teens to the Tulsa community.

5 May 2011

UCF to develop safe, inexpensive and effective polio vaccine

An innovative way of making vaccines at the University of Central Florida has attracted the support of the Bill & Melinda Gates Foundation for its potential to make vaccines lessexpensive, more effective and needle free.

5 May 2011

New research sheds light on origins of cryptococcal fungal infection

New research has shed light on the origins of a fungal infection which is one of the major causes of death from AIDS-related illnesses. The study, published today in the journal PLoS Pathogens, funded by the Wellcome Trust and the BBSRC, shows how the more virulent forms of Cryptococcus neoformans evolved and spread out of Africa and into Asia.

4 May 2011

Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine

GenVec, Inc. today announced that it has entered into a second agreement with Merial, the animal health division of sanofi-aventis.

3 May 2011

HIV drugs may also combat parasitic diseases: Study

Scientists have discovered that drugs used to treat HIV may also one day become lifesaving drugs targeted at parasitic diseases such as leishmaniasis and malaria.

3 May 2011

Opinions: Population growth; global HIV response; global malaria fight; child brides

International population dynamics are a "ticking time bomb, which we cannot afford to neglect any longer," George Tsereteli, president of the European Parliamentary Forum on Population and Development, writes in a New Europe opinion piece.

3 May 2011

Recent releases in Global Health

African Nations Rightly Proceed With DDT Plans: "Environmental activists inside and outside UNEP love to hate DDT and will seemingly stop at nothing to ensure it is never produced or used. But there is a macabre irony in their anti-DDT campaigns. With all the technological advancement of the 21st century that now ensures the average person born today will live longer than at any time in human history, SADC will be producing a chemical first synthesized in the 1800s.

30 Apr 2011

Researchers unravel mechanism behind sickle hemoglobin protection against malaria

The latest issue of the journal Cell carries an article that is likely to help solve one of the long-standing mysteries of biomedicine. In a study that challenges currently held views, researchers at the Instituto Gulbenkian de Ci-ncia, in Portugal, unravel the molecular mechanism whereby sickle cell hemoglobin confers a survival advantage against malaria, the disease caused by Plasmodium infection.

29 Apr 2011

Cerus first quarter total revenue is $6.6 million for 2011

Cerus Corporation today announced financial results for the first quarter ended March 31, 2011.

28 Apr 2011

Malaria News and Research

Latest Malaria News and Research

GlobalPost examines Pres. Obama's Global Health Initiative

HIV drugs can be used to target malaria and other parasitic diseases

Uganda: First vaccination for GMZ2 malaria vaccine trial

World's first urine-based tuberculosis diagnostics tool

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Cempra to present solithromycin Phase 1 study data at ECCMID/ICC meeting

African Progress Panel report highlights status of African economies at World Economic Forum on Africa

Opinions: U.S. support for maternal, child health; infection control at borders; the AMFm model; International Affairs budget; organizations supporting women

Ben-Gurion U. researcher receives Gates Foundation grant to develop fast, low-cost malaria device

Anacor first quarter revenues increase to $2.2 million

NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign

UCF to develop safe, inexpensive and effective polio vaccine

New research sheds light on origins of cryptococcal fungal infection

Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine

HIV drugs may also combat parasitic diseases: Study

Opinions: Population growth; global HIV response; global malaria fight; child brides

Recent releases in Global Health

Researchers unravel mechanism behind sickle hemoglobin protection against malaria

Cerus first quarter total revenue is $6.6 million for 2011

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in